FGF21 and fatty liver disease: Anti-inflammatory effects of exogenous FGF21 were demonstrated to be mediated by an inhibition of nuclear factor-κB signaling pathway in different tissues, particularly under pathophysiological conditions, including mouse models of fatty liver [44, 58, 59].